Page last updated: 2024-08-21

vincamine and Lung Neoplasms

vincamine has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arora, S; Bhatti, JS; Khurana, A; Kumar, R; Navik, U; Rajput, S; Verma, A; Verma, S; Yadav, P	1

Other Studies

1 other study(ies) available for vincamine and Lung Neoplasms

Article	Year
ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung Cancer Development by Vincamine. Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:13 Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Molecular Docking Simulation; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Vincamine	2023

Article

Year

ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung Cancer Development by Vincamine.

Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:13

Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Molecular Docking Simulation; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Vincamine

2023